Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
News
How a controversial R&D tax change could impact ASX small caps
Health & Biotech
Medlab scores export licence for cannabis mouth spray; shares get high
Health & Biotech
Zelda does pot pills deal with tech wreck 1-Page’s new German arm
Health & Biotech
Brain cancer fighter Patrys is a 10-bagger – which of these noggin-focused stocks will be next?
Health & Biotech
‘Terrific opportunity’: PharmAust boss swaps doggy cancer for Zelda cannabis gig
Health & Biotech
Which ASX pot stocks hold those golden Aussie cannabis licences
Health & Biotech
Investors cool on cannabis as scandals smoke out fearful traders
News
ASX opens down 2.6pc after Dow plunge; cannabis, crypto stocks hurt yesterday
Health & Biotech
Five ASX medical cannabis stocks racing to find a treatment for bad skin
Health & Biotech
No money in marijuana yet: Aussie pot stocks still not making cash from cannabis
Health & Biotech
It’s cannabis-induced euphoria as ASX pot stocks double in a month
Health & Biotech